Premature adrenarche leads to polycystic ovary syndrome? Long-term consequences

Annals of the New York Academy of Sciences

Volumn 1092, Issue , 2006, Pages 148-157

  Kousta, Eleni ^a  

^a Department in Endocrinology and Diabetes ^*  (Greece)

Author keywords

Long term consequences; Polycystic ovaries; Premature adrenarche

Indexed keywords

ANDROGEN SYNTHESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONFERENCE PAPER; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RELEASE; INTRAUTERINE GROWTH RETARDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PRECOCIOUS PUBERTY; SEXUAL DEVELOPMENT; FEMALE; PATHOPHYSIOLOGY; REVIEW;

FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; PUBERTY, PRECOCIOUS;

EID: 34247269615     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1365.013     Document Type: Conference Paper

References (48)

1. IBANEZ, L., et al. 2000. Premature adrenarche - normal variant or forerunner of adult disease? Endocr. Rev. 21: 671-696.
2. POTAU, N., et al. 1999. Pronounced adrenarche and precocious pubarche in boys. Horm. Res. 51: 238-241.
3. DENBURG, M.R., et al. 2002. Insulin sensitivity and the insulin-like growth factor system in prepubertal boys with premature adrenarche. J. Clin. Endocrinol. Metab. 87: 5604-5609.
4. FRANKS, S. 1995. Polycystic ovary syndrome. N. Engl. J. Med. 333: 853-861.
5. THE ROTTERDAM ESHRE/ASRM-SPONSORED PCOS CONSENSUSWORKSHOP GROUP. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19: 41-47.
6. SIGURJONSDOTTIR, T.J. & A.S. HAYLES. 1968. Premature pubarche. Clin. Pediatr. (Phila.) 7: 29-33.
7. HERMAN-GIDDENS, M.E., et al. 1997. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings Network. Pediatrics 99: 505-512.
8. ZUKAUSKAITE, S., et al. 2005. Onset of breast and pubic hair development in 1231 preadolescent Lithuanian schoolgirls. Arch. Dis. Child. 90: 932-936.
9. REMER, T. & F. MARZ. 1999. Role of nutritional status in the regulation of adrenarche.. J. Clin. Endocrinol. Metab. 84: 3936-3944.
10. JABBAR, M., et al. 1991. Excess weight and precocious pubarche in children: alterations of the adrenocortical hormones. J. Am. Coll. Nutr. 10: 289-296.
11. VOUTILAINEN, R., J. PERHEENTUPA & D. APTER. 1983. Benign premature adrenarche: clinical features and serum steroid levels. Acta Paediatr. Scand. 72: 707-711.
12. IBANEZ, L., N. POTAU & A. CARRASCOSA. 1997. Androgens in adrenarche and pubarche. In Androgen Excess Disorders. R.A. Women, J.E. Nestler & D. Dewailly, Eds.: 73-84. Lippincott-Raven. Philadelphia.
13. ROSENFIELD, R.L. 1994. Normal and almost normal precocious variations in pubertal development: premature pubarche and premature thelarche revisited. Horm. Res. 41: 7-13.
14. LEE, P.A. & F.J. GAREIS. 1976. Gonadotropin and sex steroid response to luteinizing-hormone-releasing hormone in patients with premature adrenarche. J. Clin. Endocrinol. Metab. 43: 195-197.
15. IBANEZ, L., et al. 1992. Natural history of premature pubarche: an auxological study. J. Clin. Endocrinol. Metab. 74: 254-257.
16. PERE, A., et al. 1995. Follow-up of growth and steroids in premature adrenarche. Eur. J. Pediatr. 154: 346-352.
17. SAENGER, P. & E.O. REITER. 1992. Premature adrenarche: a normal variant of puberty? J. Clin. Endocrinol. Metab. 74: 236-238.
18. YEN, S.S.C. 1986. Chronic anovulation caused by peripheral endocrine disorders. In Reproductive Endocrinology. S.C.C. Yen & R.B. Jaffe, Eds.: 441-499. Saunders. Philadelphia.
19. BRIDGES, N.A., et al. 1995. Ovaries in sexual precocity. Clin. Endocrinol. (Oxf.) 42: 135-140.
20. IBANEZ, L., F. DE ZEGHER & N. POTAU. 1993. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab. 76: 1599-1603.
21. IBANEZ, L., et al. 1999. Anovulation after precocious pubarche: early markers and time course in adolescence. J. Clin. Endocrinol. Metab. 84: 2691-2695.
22. IBANEZ, L., et al. 1997. Hyperinsulinemia and decreased insulin-like growth factor binding protein-1 are common features in prepubertal and postpubertal girls with a history of premature pubarche. J. Clin. Endocrinol. Metab. 82: 2283-2288.
23. IBANEZ, L., et al. 1996. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab. 81: 1237-1243.
24. VUGUIN, P., et al. 1999. The role of insulin sensitivity, insulin-like growth factor-I and insulin-like growth factor binding proteins 1 and 3 in the hyperandrogenism of African American and Caribbean Hispanic girls with premature adrenarche. J. Clin. Endocrinol. Metab. 84: 2037-2042.
25. GUVEN, A., P. CINAZ & A. BIDECI. 2005. Is premature adrenarche a risk factor for atherogenesis? Pediatr. Int. 47: 20-25.
26. DIMARTINO-NARDI, J. 1999. Premature adrenarch: findings in prepubertal African-American and Caribbean-Hispanic girls. Acta Paediatr. Suppl. 433: 1-6.
27. IBANEZ, L., et al. 1998. Hyper-insulinemia, dyslipidemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 41: 1057-1063.
28. IBANEZ, L., et al. 1999. Increased prevalence of unknown type 2 diabetes mellitus and impaired glucose tolerance in first-degree relatives of girls with a history of precocious pubarche. Clin. Endocrinol. (Oxf.) 51: 395-401.
29. BARKER, D.J.P., et al. 1993. Type 2 diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36: 62-67.
30. IBANEZ, L., et al. 1998. Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J. Clin. Endocrinol. Metab. 83: 3558-3662.
31. NEVILLE, K.A. & J.L. WALKER. 2005. Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity. Arch. Dis. Child. 90: 258-261.
32. STEIN, I.F. & M.L. LEVENTHAL. 1935. Amenorrhea associated with bilateral polycystic ovaries. Am. J. Obstet. Gynecol. 29: 181-191.
33. KNOCHENHAUER, E.S., et al. 1998. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J. Clin. Endocrinol. Metab. 83: 3078-3082.
34. DUNAIF, A. 1997. Insulin resistance and the polycystic ovary syndrome: mechanism of action and implications for pathogenesis. Endocr. Rev. 18: 774-800.
35. ABBOTT, D.H., D.A. DUMESIC & S. FRANKS. 2002. Developmental origin of polycystic ovary syndrome - a hypothesis. J. Endocrinol. 174: 1-5.
36. DUNAIF, A. & D.T. FINEGOOD. 1996. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 81: 942-947.
37. ASUNCION, M., et al. 2000. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasianwomen from Spain. J. Clin. Endocrinol. Metab. 85: 2434-2438.
38. HAMILTON-FAIRLEY, D., et al. 1992. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br. J. Obstet. Gynaecol. 99: 128-131.
39. EHRMANN, D.A., et al. 1999. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22: 141-146.
40. LEGRO, R.S., et al. 1999. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affectedwomen. J. Clin. Endocrinol. Metab. 84: 165-169.
41. WILD, S., et al. 2000. Cardiovascular disease in women with polycystic ovary syndrome at long-termfollow-up: a retrospective cohort study. Clin. Endocrinol. (Oxf.). 52: 595-600.
42. PIERPOINT, T., et al. 1998. Mortality of women with polycystic ovary syndrome at long-term follow-up. J. Clin. Epidemiol. 51: 581-586.
43. LEWY, V.D., et al. 2001. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J. Pediatr. 138: 38-44.
44. PALMERT, M.R., et al. 2002. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87: 1017-1023.
45. TALBOTT, E., et al. 1998. Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J. Clin. Epidemiol. 51: 415-422.
46. MATHER, K.J., F. KWAN & B. CORENBLUM. 2000. Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil. Steril. 73: 150-156.
47. ORIO, F.J., et al. 2004. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 89: 4588-4593.
48. KELLY, C.C., et al. 2001. Low grade chronic inflammation in women with polycystic ovarian syndrome. J. Clin. Endocrinol. Metab. 86: 2453-2455.